Publications (280) Publications de GUILLERMO RUIZ IRASTORZA

2024

  1. Anti-KIF20B autoantibodies are associated with cranial neuropathy in systemic lupus erythematosus

    Lupus Science and Medicine, Vol. 11, Núm. 1

  2. Anticoagulant and non-anticoagulant therapy in thrombotic antiphospholipid syndrome: old drugs and new treatment targets

    Rheumatology (United Kingdom), Vol. 63, Núm. SI, pp. SI96-SI106

  3. Balancing risks and benefits in the use of hydroxychloroquine and glucocorticoids in systemic lupus erythematosus

    Expert Review of Clinical Immunology, Vol. 20, Núm. 4, pp. 359-373

  4. Clinical Predictors of Mood Disorders and Prevalence of Neuropsychiatric Symptoms in Patients with Systemic Lupus Erythematosus

    Journal of Clinical Medicine, Vol. 13, Núm. 18

  5. Elucidating the mechanisms and efficacy of antimalarial drugs in systemic lupus erythematosus

    Expert Opinion on Pharmacotherapy, Vol. 25, Núm. 15, pp. 2047-2060

  6. Is it safe to withdraw low-dose glucocorticoids in SLE patients in remission?

    Autoimmunity Reviews, Vol. 23, Núm. 1

  7. Methylprednisolone Pulses and Prolonged Remission in Systemic Lupus Erythematosus: A Propensity Score Analysis of the Longitudinal Lupus-Cruces-Bordeaux Inception Cohort

    Arthritis Care and Research, Vol. 76, Núm. 8, pp. 1132-1138

  8. No Effect of Low-Dose Glucocorticoid Maintenance Therapy on Damage in SLE Patients in Prolonged Remission: A Propensity Score Analysis of the Longitudinal Lupus-Cruces-Bordeaux Inception Cohort

    Journal of Clinical Medicine, Vol. 13, Núm. 20

  9. OMERACT systemic lupus erythematosus domain survey

    Seminars in Arthritis and Rheumatism, Vol. 68

  10. Obstetric antiphospholipid syndrome

    Medicina Clinica, Vol. 163, pp. S14-S21

  11. Orbital/ocular inflammatory involvement in VEXAS syndrome: Data from the international AIDA network VEXAS registry

    Seminars in Arthritis and Rheumatism, Vol. 66

  12. Remission and low disease activity are associated with lower healthcare costs: results from the Systemic Lupus International Collaborating Clinics (SLICC) inception cohort

    Annals of the Rheumatic Diseases

  13. Routine biomarker profile for the prediction of clinical phenotypes of adult-onset Still's disease using unsupervised clustering algorithm

    International Journal of Rheumatic Diseases, Vol. 27, Núm. 4

  14. Thrombosis recurrence and major bleeding in non-anticoagulated thrombotic antiphospholipid syndrome patients: Prospective study from antiphospholipid syndrome alliance for clinical trials and international networking (APS ACTION) clinical database and repository (“Registry”)

    Seminars in Arthritis and Rheumatism, Vol. 65

  15. Thrombotic antiphospholipid syndrome: From guidelines to clinical management

    Medicina Clinica, Vol. 163, pp. S22-S30

  16. Use of Glucocorticoids in SLE: A Clinical Approach

    Mediterranean Journal of Rheumatology, Vol. 35, pp. 342-353

2023

  1. ANCA-associated pulmonary-renal syndrome treated with cyclophosphamide, rituximab, repeated methyl-prednisolone pulses and a reduced oral glucocorticoid regime: an observational study

    Clinical and experimental rheumatology, Vol. 41, Núm. 4, pp. 928-935

  2. Anti–Neutrophil Extracellular Trap Antibodies in Antiphospholipid Antibody–Positive Patients: Results From the Antiphospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking Clinical Database and Repository

    Arthritis and Rheumatology, Vol. 75, Núm. 8, pp. 1407-1414

  3. Assessing the Costs of Neuropsychiatric Disease in the Systemic Lupus International Collaborating Clinics Cohort Using Multistate Modeling

    Arthritis Care and Research, Vol. 75, Núm. 9, pp. 1859-1870

  4. Association Between Severe Nonadherence to Hydroxychloroquine and Systemic Lupus Erythematosus Flares, Damage, and Mortality in 660 Patients From the SLICC Inception Cohort

    Arthritis and Rheumatology, Vol. 75, Núm. 12, pp. 2195-2206